West Virginia University, Robert C. Byrd Health Sciences Center
Mary Babb Randolph Cancer Center
Healthcare at West Virginia University: To Understand. To Prevent. To Treat.
West Virginia University, Robert C. Byrd Health Sciences Center WVU Home Contact Us WVU Directory Campus Map A-Z WVU Site Index Mary Babb Randolph Cancer Center
Go
Saturday, September 06, 2008
The Ivanov Laboratory
Recent Publications
 

1.   Agapova, L.S, Ivanov, A.V., Sablina, A.A., Kopnin, P.B., Sokova, O.I., Chumakov, P.M., Kopnin, B.P. 1999. p53-Dependent Effects of RAS Oncogene on Chromosome Stability and Cell Cycle Checkpoints. Oncogene. 18:3135-3142.

2.   Ivanov, A.V., Kopnin, P.B., Kondratov, R.V., Osovskaya, V.S., Kopnin, B.P., Chumakov, P.M. 2000. Mutation in p53 Is Required for Stable Transformation of REF52 Fibroblasts by Cooperating Oncogenes Myc Plus Ras. Molecular Biology (Moscow). 34:316-325.

3.   Nabirochkina, E.N., Ivanov, A.V. 2000. Treatment by Methyl Methanesulfonate Induces Up-Regulation of Cytomegalovirus Immediate/Early Promoter. BioTechniques. 29:732-736.

4.   Alexandrova, A., Ivanov, A., Chumakov, P., Kopnin, B., Vasiliev, J. 2000. Changes in p53 Expression in Mouse Fibroblasts Can Modify Motility and Extracellular Matrix Organization. Oncogene. 19:5826-5830.

5.   Smirnov, A.S., Ruzov, A.S., Budanov, A.V., Prokhortchouk, A.V., Ivanov, A.V., Prokhortchouk, E.B. 2001. High Constitutive Level of NF-kappaB is Crucial for Viability of Adenocarcinoma Cells. Cell Death and Differentiation. 8:621-630.

6.   Pugacheva, E.N., Ivanov, A.V., Levine, A.J., Kopnin, B.P., Chumakov, P.M. 2002. Activation of dUTPase Gene Expression and Resistance to Fluoropyrimidines as a Novel Gain of Function Activity of p53 Mutants. Oncogene. 21: 4595-4600.

7.   Razorenova OV, Ivanov AV, Budanov AV, Chumakov PM. 2005. Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene. 350(1):89-98.

8.   Wang, C., Ivanov, A., Chen, L., Fredericks, W., Seto, E., Rauscher, III, F., and Chen, J. 2005. MDM2 Interaction with Nuclear Corepressor KAP-1 Contributes to p53 Inactivation. EMBO J. 24(18):3279-90.

9.   Negorev, D.G., Vladimirova, O.V., Ivanov, A., Rauscher, F. III, and Maul, G.G. 2006. Differential Role of Sp100 Isoforms in Interferon-Mediated Repression of Herpes Simplex Virus Type 1 Immediate-Early Protein Expression. J. Virology, 80(16): 8019-8029.

10. S. Dadke, S. Cotteret, S-C. Yip, Z. M. Jaffer, F. Haj, A. Ivanov, F. J. Rauscher, III, K. Shuai, T. Ng, B. G. Neel, and J. Chernoff. 2007. Regulation of Protein Tyrosine Phosphatase (PTP) 1B by sumoylation. Nature Cell Biology, 9(1):80-85.

11. D. White, D. Negorev, H. Peng, A. Ivanov, G. Maul, and F. Rauscher 3rd. 2007. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Research, 66(24): 11594-9.

12. G. Ivanov, T. Ivanova, J. Kurash, A. Ivanov, S. Chuikov, F. Gizatullin, E. Herrera-Medina, F. Rauscher III, D. Reinberg, and N. Barlev. 2007. Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage. Molecular and Cellular Biology, 27(19):6756-69.

13. A. Ivanov, H. Peng, V. Yurchenko, D. Negorev, W. Fredericks, G. Maul, M. Sadofsky, M.-M. Zhou, F. Rauscher III. 2007. PHD Domain-mediated E3 Ligase Activity Directs Intramolecular Sumoylation of an Adjacent Bromo Domain which is Required for Gene Silencing. Molecular Cell, 28: 823-37)

14. K. Sarma, R. Margueron, A. Ivanov, V. Pirotta and D. Reinberg. 2008. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Molecular and Cellular Biology, 28(8):2718-31.

15. L. Zeng; K. L. Yap; A.V. Ivanov; X. Wang; S. Mujtaba; O. Plotnikova; F.J. Rauscher, III; M.-M. Zhou. 2008. Structural Insights into Human KAP1 PHD Finger-Bromodomain and Its Role in Gene Silencing. Nature Structural and Molecular Biology, in press, DOI 10.1038/nsmb.1416.

.
MBRCC Cancer Center | P.O. Box 9300 | Morgantown, WV 26506-9300
Contact the Webmaster
Last Modified: May 22, 2008
© 2008 WVU Hospitals. All Rights Reserved.